News Roundup: March 14 to March 18
Your weekly roundup of the latest news from Drug Topics®.
Iowa Senator Pushes for PBM Investigation
Iowa Senator Chuck Grassley is pushing the FTC to investigate PBM practices.
Verapamil Shows Promise as Type 1 Diabetes Treatment
Patients taking the blood pressure medication required less insulin and demonstrated immunomodulatory benefits.
Adjuvant Olaparib Approved for Gerline BRCA-Mutated HER2-Negative Early Breast Cancer
Approval was based on results of the phase 3 OlympiA trial.
Educating Family on Naloxone and Overdoses
A group of specialists discuss overdoses and treatment with naloxone so family and caregivers are prepared for the future and for treatment.
OTC Drug Interactions in the Cough and Cold Aisle
OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
